|
Roldán V, Marín F, Lip GY. Edoxaban in Japanese patients with nonvalvular atrial fibrillation: not the same dose for everybody. Circ J. 2012;76(8):1826-7. Epub 2012 Jul 29. PubMed PMID: 22785373.
AÑO: 2012; IF: 3.578
|
|
Gallego P, Roldán V, Marín F, Jover E, Manzano-Fernández S, Valdés M, Vicente V, Lip GY. Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation. Eur J Clin Invest. 2012 Dec;42(12):1302-8. doi: 10.1111/eci.12004. Epub 2012 Oct 11. PubMed PMID: 23057651.
AÑO: 2012; IF: 3.365
|
|
Hernández-Romero D, Marín F, Roldán V, Lip GY. Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients. J Intern Med. 2012 Oct;272(4):409. doi: 10.1111/j.1365-2796.2012.02565.x. Epub 2012 Jul 27. PubMed PMID: 22702474.
AÑO: 2012; IF: 6.455
|
|
Roldán V., Marín F., Gallego P., Vicente V., Lip G.Y.H. High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: A reply to a rebuttal. Journal of Thrombosis and Haemostasis. November 2012. 10:2414-2415. 10.1111/j.1538-7836.2012.04918.x
AÑO: 2012; IF: 6.081
|
|
Andreu JM, Roldán V, García-Navarro M, Ruipérez JA, Valdés M, Marín F. [Should we add antiplatelet therapy to oral anticoagulation in patients with atrial fibrillation and vascular disease? Review of available evidence]. Arch Cardiol Mex. 2012 Jul-Sep;82(3):248-51. doi: 10.1016/j.acmx.2012.03.002. Epub 2012 Sep 14. Spanish. PubMed PMID: 23021363.
AÑO: 2012; IF: 4.78
|